| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/09/2011 | WO2011109587A1 Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators |
| 09/09/2011 | WO2011109579A1 Crystalline alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid and methods for preparing thereof |
| 09/09/2011 | WO2011109464A1 Deuterated tetrahydronaphthalene derivatives |
| 09/09/2011 | WO2011109333A1 6 -benzylphenyl- 2 - sulfurterahydropyran-3, 4, 5 -triol derivatives as inhibitors of sodium -glucose cotrans porters 1 and 2 for use in diabetic patients |
| 09/09/2011 | WO2011109324A1 Tetrazole compounds which selectively modulate the cb2 receptor |
| 09/09/2011 | WO2011109298A2 Therapeutic dll4 binding proteins |
| 09/09/2011 | WO2011108955A1 Multi -targeting system comprising a nanocarrier, nucleic acid(s) and non-nucleic acid based drug(s) |
| 09/09/2011 | WO2011108711A1 Model animal for pregnancy-induced hypertension syndrome, and treatment method therefor |
| 09/09/2011 | WO2011108624A1 Polymer of nitrogen-containing compound, method for producing same, and gene transfer agent |
| 09/09/2011 | WO2011107705A1 Ketobenzofuran derivatives, method for synthesising same, and intermediates |
| 09/09/2011 | WO2011107608A1 Heterocyclic amides as rock inhibitors |
| 09/09/2011 | WO2011107023A1 Compounds for preventing and treating disorders of metabolism and uses thereof |
| 09/09/2011 | WO2011106951A1 Compound pharmaceutical composition of levoamlodipine |
| 09/09/2011 | WO2011062903A9 Slow infusion of sulcardine and its salts |
| 09/09/2011 | CA2792093A1 Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport |
| 09/09/2011 | CA2791715A1 Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators |
| 09/09/2011 | CA2791631A1 Therapeutic dll4 binding proteins |
| 09/09/2011 | CA2791482A1 Ketobenzofuran derivatives, method for synthesising same, and intermediates |
| 09/09/2011 | CA2791338A1 Heterocyclic amides as rock inhibitors |
| 09/09/2011 | CA2791300A1 6-benzylphenyl-2-sulfurterahydropyran-3,4,5-triol derivatives as inhibitors of sodium-glucose cotransporters 1 and 2 for use in diabetic patients |
| 09/09/2011 | CA2754839A1 Pharmaceutical composition comprising levamlodipine and chlorthalidone |
| 09/08/2011 | US20110218517 In vivo chemical stabilization of vulnerable plaque |
| 09/08/2011 | US20110218380 Magnetic nanoparticle and group of nanoparticles |
| 09/08/2011 | US20110218243 Compositions and methods for treating and/or preventing cardiovascular disease |
| 09/08/2011 | US20110218232 Inhibitors of MRP4 and Agents Stimulating MRP4 Activity for the Treatment of Cardiac Disorders |
| 09/08/2011 | US20110218230 Natriuretic peptide related fragment in cardiovascular disease |
| 09/08/2011 | US20110218228 Crystalline sodium atorvastatin |
| 09/08/2011 | US20110218224 Crystalline alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid and methods for preparing thereof |
| 09/08/2011 | US20110218223 Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy |
| 09/08/2011 | US20110218221 Novel histone deacetylase inhibitors, process for preparation and uses thereof |
| 09/08/2011 | US20110218208 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases |
| 09/08/2011 | US20110218207 Isotopically enriched arylsulfonamide ccr3 antagonists |
| 09/08/2011 | US20110218202 Soluble guanylate cyclase activators |
| 09/08/2011 | US20110218197 Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators |
| 09/08/2011 | US20110218194 Heterocyclic aspartyl protease inhibitors |
| 09/08/2011 | US20110218193 Novel tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same |
| 09/08/2011 | US20110218186 Spirocyclic heterocyclic derivatives and methods of their use |
| 09/08/2011 | US20110218179 Treatment of lupus nephritis using laquinimod |
| 09/08/2011 | US20110218174 Novel cyclic benzimidazole derivatives useful as anti-diabetic agents |
| 09/08/2011 | US20110218173 Inclusion complexes of pinocembrin with cyclodextrin or its derivatives |
| 09/08/2011 | US20110218162 15-thia steroid compounds and compositions |
| 09/08/2011 | US20110218161 Cycloastragenol monoglucoside, preparation, pharmaceutical composition and application thereof |
| 09/08/2011 | US20110218159 Methods of using inhibitors of sodium-glucose cotransporters 1 and 2 |
| 09/08/2011 | US20110218144 Method of Reducing Deleterious Effects of Ischemia-Reperfusion |
| 09/08/2011 | US20110218143 Compositions and methods for tissue repair |
| 09/08/2011 | US20110217401 Aging-Related Circulating Particle-Associated Lipoprotein B Oxidase (apoBNOX) and Inhibitors Thereof |
| 09/08/2011 | US20110217371 Controlled-release microparticles and method of preparing same |
| 09/08/2011 | US20110217369 Fenofibrate compositions |
| 09/08/2011 | US20110217368 Bacterial compositions for prophylaxis and treatment of degenerative disease |
| 09/08/2011 | US20110217336 Chronotherapeutic dosage forms and methods of treatment using chronotherapy |
| 09/08/2011 | US20110217335 Synthesis of resorcylic acid lactones useful as therapeutic agents |
| 09/08/2011 | US20110217311 Cycloalkyl containing thienopyrimidines for pharmaceutical compositions |
| 09/08/2011 | US20110217308 Compositions and methods using recombinant MHC molecules for the treatment of stroke |
| 09/08/2011 | US20110217306 C-terminal exon 5.4 of runx1/aml1 |
| 09/08/2011 | US20110217301 Methods for treating or screening for compounds for the treatment of sepsis |
| 09/08/2011 | US20110217293 Uses of morelloflavone |
| 09/08/2011 | US20110217285 Keratin biomaterials for treatment of ischemia |
| 09/08/2011 | US20110217279 Use of human biliverdin reductase and fragments thereof for the treatment of protein kinase c-delta and erk related conditions |
| 09/08/2011 | US20110217272 Treatment of radiation injury using placental stem cells |
| 09/08/2011 | US20110217271 Treatment of diseases or disorders using placental stem cells |
| 09/08/2011 | US20110217251 Therapeutic compositions comprising polyhydroxyltate fatty alcohol derivatives and uses thereof |
| 09/08/2011 | US20110217237 Therapeutic dll4 binding proteins |
| 09/08/2011 | DE102009046115A1 Substituierte 3-Phenylpropansäuren und ihre Verwendung Substituted 3-Phenylpropansäuren and their use |
| 09/07/2011 | EP2363484A2 Humanized antibody against human tissue factor (TF) and process of production of the humanized antibody |
| 09/07/2011 | EP2363405A1 Anti-infarction molecules |
| 09/07/2011 | EP2363394A1 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorders |
| 09/07/2011 | EP2363152A1 Cardiac arrhythmia treatment methods |
| 09/07/2011 | EP2363142A1 Elastase for opening obstructed biological conduits |
| 09/07/2011 | EP2363124A1 Pharmaceutical compositions comprising droxidopa |
| 09/07/2011 | EP2363123A1 Pharmaceutical compositions comprising droxidopa |
| 09/07/2011 | EP2362876A1 Thienotriazolodiazepine derivatives active on apo a |
| 09/07/2011 | EP2362773A1 Methods for inducing programmed cell death |
| 09/07/2011 | EP2362770A2 Compositions and methods for treating or preventing radiation injury |
| 09/07/2011 | EP2029591B1 Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof |
| 09/07/2011 | CN1660433B Combination of treating and/or preventing hemorrhoid |
| 09/07/2011 | CN1660429B New application of inhibitor of matrix metal metal protease (MMP) in use for treating hemorrhoid |
| 09/07/2011 | CN1660428B New application of synthase inhibitor of nitric in use for treating hemorrhoid |
| 09/07/2011 | CN102177178A Anti-IL-12/IL-23 antibodies |
| 09/07/2011 | CN102177137A 1-phenylpyrrole compounds |
| 09/07/2011 | CN102177133A Tetrahydronaphthalene compounds |
| 09/07/2011 | CN102176900A Pharmaceutical compositions and related methods of delivery |
| 09/07/2011 | CN102175682A Bioactivity detection method and application of recombined humanized neuroglobin |
| 09/07/2011 | CN102174119A Selenized carrageenan and preparation method thereof |
| 09/07/2011 | CN102174102A Stable analogs of peptide and polypeptide therapeutics |
| 09/07/2011 | CN102174073A Oyster protein peptide and zinc chelate and method for preparing same |
| 09/07/2011 | CN102174065A Triazolyl containing pentacyclic triterpenoid derivatives and preparation method and medicinal application thereof |
| 09/07/2011 | CN102174046A Tetomilast polymorphs |
| 09/07/2011 | CN102174045A Tetomilast polymorphs |
| 09/07/2011 | CN102174044A Tetomilast polymorphs |
| 09/07/2011 | CN102172400A Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 09/07/2011 | CN102172393A Calcium supplement of fish scale protein peptide calcium chelate and preparation method thereof |
| 09/07/2011 | CN102172392A Chinese medicine for treating diabetic acro-necrosis |
| 09/07/2011 | CN102172391A Traditional Chinese medicine for treating diabetic foot |
| 09/07/2011 | CN102172382A Traditional Chinese medicine for treating diabetic retinopathy |
| 09/07/2011 | CN102172378A Traditional Chinese medicine for treating diabetic coronary heart disease |
| 09/07/2011 | CN102172370A Method for separating decumbent corydalis tuber total alkaloid with ion exchange resin |
| 09/07/2011 | CN102172367A Traditional Chinese medicine for treating diabetic heart disease |
| 09/07/2011 | CN102172366A Method for separating total alkaloids from motherwort by using ion exchange resin |
| 09/07/2011 | CN102172365A Method for separating radix sophorae flavescentis total alkaloids by ion exchange resin |
| 09/07/2011 | CN102172357A Core 2 glcnac-t inhibitors |